Journal of oncology
Saif MW, Makrilia N, Syrigos K.
PMID: 21209714
J Oncol. 2010;2010:934359. doi: 10.1155/2010/934359. Epub 2010 Dec 16.
Intracellular reduced folate exists as a "pool" of more than 6 interconvertable forms. One of these forms, 5,10 methylenetetrahydrofolic acid (CH(2)THF), is the key one-carbon donor and reduced folate substrate for thymidylate synthase (TS). This pathway has been an...
Cite
Saif MW, Makrilia N, Syrigos K. CoFactor: Folate Requirement for Optimization of 5-Fluouracil Activity in Anticancer Chemotherapy. J Oncol. 2010;2010:934359doi: 10.1155/2010/934359.
Saif, M. W., Makrilia, N., & Syrigos, K. (2010). CoFactor: Folate Requirement for Optimization of 5-Fluouracil Activity in Anticancer Chemotherapy. Journal of oncology, 2010934359. https://doi.org/10.1155/2010/934359
Saif, Muhammad Wasif, et al. "CoFactor: Folate Requirement for Optimization of 5-Fluouracil Activity in Anticancer Chemotherapy." Journal of oncology vol. 2010 (2010): 934359. doi: https://doi.org/10.1155/2010/934359
Saif MW, Makrilia N, Syrigos K. CoFactor: Folate Requirement for Optimization of 5-Fluouracil Activity in Anticancer Chemotherapy. J Oncol. 2010;2010:934359. doi: 10.1155/2010/934359. Epub 2010 Dec 16. PMID: 21209714; PMCID: PMC3010680.
Copy
Download .nbib
